The functional coupling of neuronal and extraneuronal transport with intracellular monoamine oxidase
- PMID: 3295118
- DOI: 10.1007/978-3-7091-8901-6_6
The functional coupling of neuronal and extraneuronal transport with intracellular monoamine oxidase
Abstract
"Metabolizing systems" are responsible for the quick inactivation of noradrenaline released from adrenergic nerve endings: a transport mechanism (uptake1 or uptake2) is arranged in series with the intracellular enzyme (monoamine oxidase, MAO; catechol-O-methyltransferase, COMT). In the perfused rat heart, kenzyme-values were determined, i.e., those rate constants which characterize the unsaturated intracellular enzymes. In the extraneuronal metabolizing system kcomt greater than kmao for noradrenaline and adrenaline, while rather similar rate constants were obtained for dopamine. However, for the neuronal deaminating system, kmao is considerably higher than kmao for the extraneuronal system. Second, in the rat vas deferens it is demonstrated that inhibition of neuronal MAO leads to very pronounced rises of the axoplasmic noradrenaline concentration--and this is again a reflection of the high activity of neuronal MAO. In a third series of experiments (with the rat vas deferens), the evidence indicates that the neuronal inward transport of substrates of MAO fails to saturate the enzyme. This is the functional consequence of the high activity of neuronal MAO. It is concluded that a) neuronal MAO activity is very high, and--as a consequence--b) axoplasmic noradrenaline levels are very low.
Similar articles
-
The activity of the neuronal and extraneuronal catecholamine-metabolizing enzymes of the perfused rat heart.Naunyn Schmiedebergs Arch Pharmacol. 1987 Aug;336(2):139-47. doi: 10.1007/BF00165797. Naunyn Schmiedebergs Arch Pharmacol. 1987. PMID: 3683592
-
The interaction of transport mechanisms and intracellular enzymes in metabolizing systems.J Neural Transm Suppl. 1990;32:3-18. doi: 10.1007/978-3-7091-9113-2_1. J Neural Transm Suppl. 1990. PMID: 2089098 Review.
-
The effect of partial inhibition of monoamine oxidase on the steady-state rate of deamination of 3H-catecholamines in two metabolizing systems.Naunyn Schmiedebergs Arch Pharmacol. 1986 Jul;333(3):253-61. doi: 10.1007/BF00512938. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 3762740
-
Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats.Naunyn Schmiedebergs Arch Pharmacol. 1996 Apr;353(5):536-44. doi: 10.1007/BF00169173. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8740147
-
Monoamine oxidase and catecholamine metabolism.J Neural Transm Suppl. 1994;41:57-67. doi: 10.1007/978-3-7091-9324-2_7. J Neural Transm Suppl. 1994. PMID: 7931266 Review.
Cited by
-
Biochemistry and pharmacology of moclobemide, a prototype RIMA.Psychopharmacology (Berl). 1992;106 Suppl:S6-14. doi: 10.1007/BF02246225. Psychopharmacology (Berl). 1992. PMID: 1546143 Review.
-
Inhibition of rat brain monoamine oxidase enzymes by fluoxetine and norfluoxetine.Naunyn Schmiedebergs Arch Pharmacol. 1996 Jun;354(1):17-24. doi: 10.1007/BF00168701. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8832583
-
Dissipation mechanisms for 5-hydroxytryptamine in the coronary circulation of the isolated perfused heart of the rat.Br J Pharmacol. 1989 Jun;97(2):329-38. doi: 10.1111/j.1476-5381.1989.tb11958.x. Br J Pharmacol. 1989. PMID: 2474344 Free PMC article.
-
The plasma membrane monoamine transporter (PMAT): Structure, function, and role in organic cation disposition.Clin Pharmacol Ther. 2016 Nov;100(5):489-499. doi: 10.1002/cpt.442. Epub 2016 Sep 19. Clin Pharmacol Ther. 2016. PMID: 27506881 Free PMC article. Review.
-
Brain Plasma Membrane Monoamine Transporter in Health and Disease.Handb Exp Pharmacol. 2021;266:253-280. doi: 10.1007/164_2021_446. Handb Exp Pharmacol. 2021. PMID: 33751232
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous